Daniel B Kopans1. 1. Radiology, Harvard Medical School, 20 Manitoba Road, Waban, MA, 02468, USA. dkopans@verizon.net.
Abstract
PURPOSE: To evaluate the design and plan of execution of the "WISDOM" trial. METHODS: The rationale and reasoning behind the WISDOM Trial were reviewed and analyzed. The published parameters of the trial were reviewed. RESULTS: The study is based on a failed understanding of the available data about breast cancer screening and is based on faulty assumptions, false reasoning, a scientifically unsupportable study design, ignoring advances in screening, a questionable endpoint, the likely lacking of power to answer the primary question, and support by insurance companies whose primary goal is almost certainly to reduce their costs. CONCLUSION: A major part of the premise is that there is a "debate" about the efficacy of screening. WISDOM ignores the fact that the "debate" has been manufactured and is not science-based. The results of the WISDOM Trial may be misleading.
PURPOSE: To evaluate the design and plan of execution of the "WISDOM" trial. METHODS: The rationale and reasoning behind the WISDOM Trial were reviewed and analyzed. The published parameters of the trial were reviewed. RESULTS: The study is based on a failed understanding of the available data about breast cancer screening and is based on faulty assumptions, false reasoning, a scientifically unsupportable study design, ignoring advances in screening, a questionable endpoint, the likely lacking of power to answer the primary question, and support by insurance companies whose primary goal is almost certainly to reduce their costs. CONCLUSION: A major part of the premise is that there is a "debate" about the efficacy of screening. WISDOM ignores the fact that the "debate" has been manufactured and is not science-based. The results of the WISDOM Trial may be misleading.
Entities:
Keywords:
Breast cancer; Screening; Screening trials
Authors: Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok Journal: J Natl Cancer Inst Date: 2012-01-06 Impact factor: 13.506
Authors: Paul F Pinsky; Philip C Prorok; Kelly Yu; Barnett S Kramer; Amanda Black; John K Gohagan; E David Crawford; Robert L Grubb; Gerald L Andriole Journal: Cancer Date: 2016-12-01 Impact factor: 6.860